In a significant breakthrough in the fight against antibiotic-resistant sexually transmitted infections (STIs), a new oral pill, gepotidacin, has shown promising results in combating drug-resistant ...

A new pill has shown promise against antibiotic-resistant gonorrhoea -- a common sexually transmitted infection (STI) --, according to a study published in the journal The Lancet.